JCP Study of Investigation of Patient Background Characteristics
Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
To collect the background characteristics of juvenile cerebral palsy patients aged 2-year or
older prescribed BOTOX for the treatment of equines foot due to lower limb spasticity,
compare them with those of patients whose deaths or adverse drug reactions (ADRs) related to
the possible spread of toxin are reported through the spontaneous ADR reporting system, and
discuss potential risk factors for such ADRs.
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
abobotulinumtoxinA Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA